We had the great opportunity to chat with our valued European editorial board member Bengt Winblad (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) at EAN 2019. We covered aspects of ageing and dementia that were highlighted across various presentations he was involved with at the congress.
1. What have studies of the dicarboxylate clamp tetratricopeptide motif containing (dcTPR) proteins taught us about Alzheimer’s disease (AD) and other neurodegenerative diseases? (0:04)
2. Could you tell us a little about your recent study on electroencephalography (EEG) in the early detection of synaptic dysfunction in patients with AD? (2:07)
3. What are the implications of these findings for future AD research? (3:15)
4. What are the risks associated with the use of antipsychotic medications in patients with dementia? (4:02)
5. What advice would you give to clinicians considering the use of antipsychotics in their dementia patients? (5:17)
Speaker disclosure: Bengt Winblad has nothing to disclose in relation to this video interview.
Filmed at the 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 2019.
Share this Video
Related Videos In Alzheimer's Disease & Dementia
Kristian Steen Frederiksen, EAN 2023: The new EAN guidelines
Dr Kristian Steen Frederiksen (Danish Dementia Research Center, Denmark, Copenhagen) summarizes some of the key updates to the EAN guidelines, and the take-home messages presented at the annual European Academy of Neurology (EAN), July 1–4, 2023. Disclosures: Kristian Steen Frederiksen has no financial or non-financial conflicts of interest to declare in relation to this video. Support: Interview and filming was supported by Touch […]
Kristian Steen Frederiksen, EAN 2023: Highlights in Alzheimer’s disease and dementia
Dr Kristian Steen Frederiksen (Danish Dementia Research Center, Denmark, Copenhagen) discusses his highlights from the annual European Academy of Neurology (EAN), July 1–4, 2023 in the field of Alzheimer’s disease and dementia. Disclosures:Kristian Steen Frederiksen has no financial or non-financial conflicts of interest to declare in relation to this video. Support: Interview and filming was supported by Touch Medical Media. The interview was conducted by Sophie Nickelson. […]
Kristen George, AAIC 2022: Experiences of discrimination on cognitive function and ageing among the oldest old: The LifeAfter90 (LA90) Study
The LifeAfter90 (LA90) Study aims to understand what cognitive ageing and dementia look like among individuals aged 90 and above. In this interview, Dr Kristen George (University of California Davis School of Medicine, University of California, Davis, CA, USA) discussed what the study found in terms of the effect of discrimination on the cognitive function of this […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!